Pre and peri-operative erythropoeitin for reducing allogeneic blood transfusions in colorectal cancer surgery.

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: The primary objective of this systematic review is to evaluate the efficacy of erythropoietin pre and peri‐operatively, in reducing the need for allogeneic blood transfusions in patients undergoing colorectal cancer surgery. Secondary objectives are to determine whether pre and peri‐operative erythropoietin improves other hematologic parameters (hemoglobin, hemotocrit and reticulocyte count), quality of life, recurrence rate, and survival, without increased adverse events such as thrombosis and peri‐operative mortality.

Ähnliche Arbeiten